102
Participants
Start Date
June 27, 2022
Primary Completion Date
March 24, 2023
Study Completion Date
April 21, 2023
Obicetrapib
tablet
Placebo
No active ingredient
Nippon Kokan Fukuyama Hospital, Fukuyama
Nakamura Cardiology and Cardiovascular Surgery Clinic, Itoshima
Kishiwada Tokushu-Kai Hospital, Osaka
Kyosokai AMC NISHI-UMEDA Clinic, Osaka
Sakurabashi Watanabe Hospital, Osaka
Uji Tokushu-Kai Hospital, Osaka
Sanai Hospital, Saitama
Shinden Higashi Clinic, Sendai
Soka-Sugiura Clinic, Sōka
Sugiura Clinic, Tokyo
Lead Sponsor
NewAmsterdam Pharma
INDUSTRY